Results for tag: "Aptamer"

The Aptamer market is a subset of the biotechnology industry that focuses on the development and production of aptamers, which are short, single-stranded DNA or RNA molecules that can bind to specific targets. Aptamers are used in a variety of applications, including diagnostics, therapeutics, and research. Aptamers are often used as alternatives to antibodies, as they are more stable, easier to produce, and can be tailored to bind to a wide range of targets. Aptamers are produced through a process called SELEX (Systematic Evolution of Ligands by Exponential Enrichment), which involves iterative cycles of selection and amplification of aptamers that bind to the desired target. This process is often automated, allowing for the rapid production of aptamers. The Aptamer market is growing rapidly, driven by increasing demand for aptamers in research and clinical applications. Companies in the Aptamer market include Aptagen, Aptamer Solutions, Base Pair Biotechnologies, and Aptamer Group. Show Less Read more